Cargando…
Hospitalisation costs of malignant mesothelioma: results from the Italian hospital discharge registry (2001–2018)
OBJECTIVES: This paper aims to establish hospitalisation costs of mesothelioma in Italy and to evaluate hospital-related trends associated with the 1992 asbestos ban. DESIGN: This is a retrospective population-based study of Italian hospitalisations treating pleura, peritoneum and pericardium mesoth...
Autor principal: | Ferrante, Pierpaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354284/ https://www.ncbi.nlm.nih.gov/pubmed/34373297 http://dx.doi.org/10.1136/bmjopen-2020-046456 |
Ejemplares similares
-
Cost-effectiveness of nivolumab plus ipilimumab as first-line treatment for American patients with unresectable malignant pleural mesothelioma
por: Ye, Zhuo-miao, et al.
Publicado: (2022) -
Male and Female Differences in Homicide Mortality: Results of an Italian Longitudinal Study, 2012–2018
por: Ventura, Martina, et al.
Publicado: (2022) -
Disease and age pattern of hospitalisation and associated costs in India: 1995–2014
por: Kastor, Anshul, et al.
Publicado: (2018) -
Malignant brain neoplasms incidence and mortality trends in Croatia from 2001 to 2014
por: Mrak, Goran, et al.
Publicado: (2019) -
The first 2 years of COVID-19 in Italy: Incidence, lethality, and health policies
por: Ferrante, Pierpaolo
Publicado: (2022)